Gastroenterology Department, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, CIBEREHD, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain.
Genet Med. 2011 Feb;13(2):155-60. doi: 10.1097/GIM.0b013e318202e10b.
Lynch syndrome accounts for 2-4% of all colorectal cancer, and is mainly caused by germline mutations in the DNA mismatch repair genes. Our aim was to characterize the genetic mutation responsible for Lynch syndrome in an extensive Colombian family and to study its prevalence in Antioquia.
A Lynch syndrome family fulfilling Amsterdam criteria II was studied by immunohistochemistry and by multiplex ligation-dependent probe amplification (MLPA). Results were confirmed by additional independent MLPA, Southern blotting, and sequencing.
Index case tumor immunohistochemistry results were MLH1-, MSH2+, MSH6+, and PMS2-. MLPA analysis detected a duplication of exons 12 and 13 of MLH1. This mutation was confirmed and characterized precisely to span 4219 base pairs. Duplication screening in this family led to the identification of six additional carriers and 13 noncarriers. We also screened 123 early-onset independent colorectal cancer cases from the same area and identified an additional unrelated carrier.
A novel duplication of exons 12 and 13 of the MLH1 gene was detected in two independent Lynch syndrome families from Colombia. A putative founder effect and prescreening Lynch syndrome Antioquia families for this specific mutation before thorough mismatch repair mutational screening could be suggested.
林奇综合征占所有结直肠癌的 2-4%,主要由 DNA 错配修复基因的种系突变引起。我们的目的是鉴定一个广泛的哥伦比亚家族中导致林奇综合征的遗传突变,并研究其在安蒂奥基亚的流行率。
通过免疫组织化学和多重连接依赖性探针扩增(MLPA)研究符合阿姆斯特丹标准 II 的林奇综合征家族。结果通过额外的独立 MLPA、Southern 印迹和测序进行了确认。
索引病例肿瘤免疫组织化学结果为 MLH1-、MSH2+、MSH6+和 PMS2-。MLPA 分析检测到 MLH1 的外显子 12 和 13 的重复。该突变得到了证实,并精确地确定为跨越 4219 个碱基对。对该家族进行的重复筛选导致确定了另外 6 个携带者和 13 个非携带者。我们还对来自同一地区的 123 例早发性独立结直肠癌病例进行了筛查,发现了另外一个无关的携带者。
在来自哥伦比亚的两个独立林奇综合征家族中检测到 MLH1 基因的外显子 12 和 13 的新重复。可以推测存在一个假定的创始人效应,并且在进行全面的错配修复突变筛查之前,对安蒂奥基亚的林奇综合征家族进行这种特定突变的预筛选。